JSM 2015 Preliminary Program

Online Program Home
My Program

Abstract Details

Activity Number: 88
Type: Contributed
Date/Time: Sunday, August 9, 2015 : 4:00 PM to 5:50 PM
Sponsor: Biopharmaceutical Section
Abstract #315030
Title: A Modified Simon's Two-Stage Design for Phase II Clinical Trials
Author(s): Jongphil Kim* and Michael J. Schell
Companies: H. Lee Moffitt Cancer Center & Research Institute and H. Lee Moffitt Cancer Center & Research Institute
Keywords: Admissible Two-Stage Design ; Binary Endpoint ; Simon's Two-Stage Design ; Single-Arm Phase II Clinical Trials
Abstract:

Simon's two-stage design and the "admissible" two-stage design by Jung et al. have been commonly used in practice for single-arm phase II cancer clinical trials when the primary endpoint is binary. These design approaches, however, do not take into account the balance in sample size between the two stages, and thus the ethical benefit expected by the two-stage design may not be achieved if a severe imbalance in the sample sizes of the two stages is observed. In addition, investigators may desire a two-stage design which controls the probability of early termination under the alternative hypothesis (PET1) under a pre-selected level. To address these two concerns, we propose a modified Simon's two-stage design with reasonable sample size evaluated in the first stage, while maintaining the PET1 under a pre-selected level. The characteristics of the modified Simon's two-stage design will be compared to Simon's and the admissible two-stage design.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2015 program





For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home